Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?Moritz Mirna, Michael Lichtenauer, Dzeneta Fejzic et al.|Journal of Clinical Laboratory Analysis|2021Cited by 6
Deoxyribonuclease is prognostic in patients undergoing transcatheter aortic valve replacementAndreas Mangold, Michael Lichtenauer, Anna S. Ondracek et al.|European Journal of Clinical Investigation|2021Cited by 3